Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: J Neurooncol. 2018 Dec 7;141(2):327–335. doi: 10.1007/s11060-018-03034-6

Table 2:

Multivariate Cox regression analysis associated with progression-free survival.

Hazard ration (HR) 95% CI p-value
Molecular group (G vs. A/O) 5.2 3.2-7.1 0.000
Tumor size (>6cm vs. < 6cm) 1.6 1.3-2.2 0.007

Further tested variables which were not independent factors were: patients’ age at first diagnosis, contrast enhancement in the MRI, tumor crossing the midline and WHO grade II vs. III.